A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Trial ID or NCT#
This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.
A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection
- - Have previously participated in a Gilead-sponsored hepatitis C study and received at least one Gilead OAV - Have failed to achieve an SVR in a previous Gilead-sponsored study, as defined in the original treatment protocol - Provide written, informed consent - Be willing and able to comply with the visit schedule Key
- - Individuals planning to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up Registry - History of clinically significant illness or any other major medical disorder that may interfere with follow-up, assessments or compliance with the protocol Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Contact us to find out if this trial is right for you.
Mindie H. Nguyen, MD